Jacksonville, FL and Savannah, GA (PRWEB) August 23, 2013
Morphogenesis Inc., a biotechnology firm that has developed a specialized process that educates the immune system to fight cancer in dogs, cats and horses, announces the start of a field study for its personalized cancer treatment for dogs in partnership with SEVO-Med (Southeastern Veterinary Oncology and Medicine).
Tampa-based Morphogenesis and SEVO-Med, a major southeastern veterinary oncology practice which has clinics in Jacksonville and Savannah, are providing the opportunity to pet owners and veterinarians to enroll dogs with High Grade B Cell Lymphoma who might benefit from this personalized treatment.
The first 20 dogs who qualify for the study will be selected. Veterinarians and dog owners who believe their patient/pet could qualify to participate in the study should immediately contact SEVO-Med at 904-278-3870 or 912-355-5791. Once a dog is accepted into the study, treatments and study tests are provided at no cost to the owner.
The vaccine-based cancer treatments developed by Morphogenesis have been shown to manage 17 types of cancer without any side effects in canine, feline and equine patients.
In the treatment developed by Morphogenesis, the dog’s own lymphoma cells undergo a marking process that helps the animal’s immune system recognize the cells as foreign and kill them.
“We educate the body’s immune system to fight its own tumor cells,” said Pat Lawman, Ph.D., CEO of Morphogenesis. “Our process helps keep the cancer in check so that it doesn't progress, and we all think that’s a win.”
“More and more, you are seeing companion animals present with all types of cancers,” Tracy LaDue, DVM, founder of SEVO-Med, wrote in letters to veterinarians informing them of this treatment option for qualifying dogs. “The study being conducted by Morphogenesis and SEVO-Med will further demonstrate the safety and effectiveness of this cutting edge new technology in the fight against lymphoma.”
Southeast Veterinary Oncology (SEVO) was founded in the Jacksonville suburb of Orange Park, FL, in October, 2004 by double-board certified veterinary oncologist, Tracy LaDue, DVM. At that time, SEVO was one of the first oncology-specific veterinary specialty practices in the U.S. The practice opened its Savannah, GA, clinic in September of 2011. Today, the practices are led by Dr. LaDue and Jennifer Locke, DVM in Florida, and Andrew Daters, DVM, in Georgia. SEVO-Med’s mission is to understand the unique and special bond shared between you and your pet, to offer compassionate guidance, to deliver excellent state of the art medical care, to provide the utmost in client communication and to collaborate with referring veterinarians to develop the best therapy for your pet. For more information, please visit http://www.petcancercare.com or call 904-278-3870 or 912-355-5791.
Morphogenesis is a privately-held biotechnology company structured to serve the rapidly growing cell therapy, biologics and tissue engineering markets. Morphogenesis has developed a multi-indication cancer therapy which educates the immune system to attack tumor cells throughout the body without damaging other cells or systems. Its subsidiary, Veterinary Oncology Services, Inc., assists veterinary physicians in providing this non-toxic, personalized treatment for many types of cancers in cats, dogs and horses. For more information, please visit http://www.veterinaryoncologyservices.com or 813-877-7896 http://www.morphogenesis-inc.com or call 813-875-6600.
Read the full story at http://www.prweb.com/releases/2013/8/prweb11054809.htm